AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Shoulder Innovations, Inc.
XNYS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00FM5V7N5
19.66▼ 0.09 (-0.46%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
19.75
Day's Range
19.28 – 19.90
52-Week Range
10.92 – 24.60
Volume
67.3K
Avg Volume
120.4K
Share Statistics
Shares Outstanding
Employees
75
Exchange
XNYS
Listed
2025-07-31
Share count as of July 30, 2026

Shoulder Innovations, Inc. (SI) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Shoulder Innovations, Inc. (SI)
What is Shoulder Innovations, Inc.'s Market Cap?
Shoulder Innovations, Inc.'s Market Cap is $409.3M, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s Enterprise Value?
Shoulder Innovations, Inc.'s Enterprise Value is $399.7M, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s Price / Sales?
Shoulder Innovations, Inc.'s Price / Sales is 6.8×, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s EV / Revenue?
Shoulder Innovations, Inc.'s EV / Revenue is 6.7×, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s EV / EBITDA?
Shoulder Innovations, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s Revenue (TTM)?
Shoulder Innovations, Inc.'s Revenue (TTM) is $60.1M, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s Net Income (TTM)?
Shoulder Innovations, Inc.'s Net Income (TTM) is -$35.0M, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s EBITDA?
Shoulder Innovations, Inc.'s EBITDA is -$31.3M, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s Diluted EPS (TTM)?
Shoulder Innovations, Inc.'s Diluted EPS (TTM) is -1.68, based on as-reported figures from SEC (XBRL) filings.
What is Shoulder Innovations, Inc.'s EBITDA Margin?
Shoulder Innovations, Inc.'s EBITDA Margin is -52.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Net revenue
YoY growth+56.0%+64.9%+65.2%+57.7%
Cost of goods sold
Gross profit
% of revenue78.3%77.7%76.7%76.2%
Selling, general and administrative expenses (includes $862, $887, $2,101 and $1,736 to related parties, respectively)
Research and development expenses (includes $2,645, $1,060, $5,710 and $2,295 to related parties, respectively)
Operating loss
% of revenue-58.4%-53.7%-59.0%-65.0%
Other (income) expense
Interest (income) expense, net
Change in fair value of Series E purchase option—
Loss on extinguishment of debt———
Other expense, net
Total other (income) expense
Loss before income tax expense
Income tax expense
Net loss
% of revenue-59.1%-50.1%-53.9%-74.3%
Net loss per share - basic (in dollars per share)—
Net loss per share - diluted (in dollars per share)—